LivaNova (LIVN) Capital Expenditures Growth (1y) (2017 - 2026)
LivaNova (LIVN) Capital Expenditures Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | -6.52% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 108.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.29% |
| Mar 31, 2026 | -3.05% |
| Dec 31, 2025 | 209.75% |
| Sep 30, 2025 | 26.08% |
| Jun 30, 2025 | 24.61% |
| Mar 31, 2025 | 68.65% |
| Dec 31, 2024 | -19.45% |
| Sep 30, 2024 | 108.16% |
| Jun 30, 2024 | 114.81% |
| Mar 31, 2024 | -16.75% |
| Dec 31, 2023 | 41.44% |
| Sep 30, 2023 | 44.31% |
| Jun 30, 2023 | -7.64% |
| Mar 31, 2023 | 47.36% |
| Dec 31, 2022 | 20.42% |
| Sep 30, 2022 | 84.68% |
| Jun 30, 2022 | -4.30% |
| Mar 31, 2022 | -36.56% |
| Dec 31, 2021 | 15.29% |
| Sep 30, 2021 | -68.82% |